MedTrace Logo

Salivary Drug Concentration Exploratory Study of Cetylpyridinium Chloride Buccal Tablets

NCT05802628 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2023-07-12

No results posted yet for this study

Summary

The study is a single-arm, open-label study to explore the salivary concentration of Cetylpyridinium Chloride Buccal Tablets after single-dose administration in Healthy Subjects

Conditions

  • Pharyngitis Acute
  • Gingivitis

Interventions

DRUG

Cetylpyridinium Chloride Buccal Tablets

Subjects administrated single dose of Cetylpyridinium Chloride Buccal Tablet

Sponsors & Collaborators

  • Peking University People's Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-10
Primary Completion
2023-04-18
Completion
2023-04-18

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05802628 on ClinicalTrials.gov